LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zeng, Heng ^a   He, Xiaochen ^a   Tuo, Qin Hui ^b   Liao, Duan Fang ^b   Zhang, Guo Qiang ^c   Chen, Jian Xiong ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; LIPOPOLYSACCHARIDE; NOTCH3 PROTEIN, MOUSE; NOTCH3 RECEPTOR; SIRTUIN 3; TEK PROTEIN, MOUSE;

ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; HEART; INFLAMMATION; KNOCKOUT MOUSE; LUNG; METABOLISM; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; SIGNAL TRANSDUCTION;

ANGIOPOIETINS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENDOTHELIAL CELLS; HEART; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MICE, KNOCKOUT; MICROVESSELS; MODELS, BIOLOGICAL; PERICYTES; RECEPTOR, NOTCH3; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; SIRTUIN 3;

EID: 84958213599     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20931     Document Type: Article

References (48)

1. Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S., Lee, W. L. Broken barriers: a new take on sepsis pathogenesis. Sci. Transl. Med. 3, 88-25 (2011).
2. De, B. D., Orbegozo, C. D., Donadello, K., Vincent, J. L. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 5 (2013).
3. Page, A. V., Liles, W. C. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 4, 507-516 (2013).
4. Bongiovanni, D. et al. Thymosin beta4 attenuates microcirculatory and hemodynamic destabilization in sepsis. Expert. Opin. Biol. Ther. 15 Suppl 1, S203-S210 (2015).
5. Chislock, E. M., Pendergast, A. M. Abl family kinases regulate endothelial barrier function in vitro and in mice. PLoS. One. 8, e85231 (2013).
6. Ziegler, T. et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J. Clin. Invest. 123, 3436-3445 (2013).
7. Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275, 9102-9105 (2000).
8. Kwak, H. J., So, J. N., Lee, S. J., Kim, I., Koh, G. Y. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 448, 249-253 (1999).
9. Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
10. Chen, J. X., Lawrence, M. L., Cunningham, G., Christman, B. W., Meyrick, B. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J. Appl. Physiol 96, 612-620 (2004).
11. David, S., van, M. M., Kumpers, P. Does low angiopoietin-1 predict adverse outcome in sepsis? Crit Care 14, 180 (2010).
12. Mofarrahi, M. et al. Regulation of angiopoietin expression by bacterial lipopolysaccharide. Am. J. Physiol Lung Cell Mol. Physiol 294, L955-L963 (2008).
13. Darwish, I., Liles, W. C. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction. Virulence. 4, 572-582 (2013).
14. Parikh, S. M. Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS. Virulence. 4, 517-524 (2013).
15. Spicer, A., Calfee, C. S. Fixing the leak: targeting the vascular endothelium in sepsis. Crit Care 16, 177 (2012).
16. Alfieri, A. et al. Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Crit Care 16, R182 (2012).
17. Novotny, N. M. et al. Angiopoietin-1 in the treatment of ischemia and sepsis. Shock 31, 335-341 (2009).
18. Hall, E., Brookes, Z. L. Angiopoietin-1 increases arteriolar vasoconstriction to phenylephrine during sepsis. Regul. Pept. 131, 34-37 (2005).
19. Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H. P., Tschope, C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111, 97-105 (2005).
20. Green, M. F., Hirschey, M. D. SIRT3 weighs heavily in the metabolic balance: a new role for SIRT3 in metabolic syndrome. J. Gerontol. A Biol. Sci. Med. Sci. 68, 105-107 (2013).
21. Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177-190 (2011).
22. Liu, Y., Zhang, D., Chen, D. SIRT3: Striking at the heart of aging. Aging (Albany. NY) 3, 1-2 (2011).
23. Li, L., Zeng, H., Hou, X., He, X., Chen, J. X. Myocardial Injection of Apelin-Overexpressing Bone Marrow Cells Improves Cardiac Repair via Upregulation of Sirt3 after Myocardial Infarction. PLoS. One. 8, e71041 (2013).
24. Kidoya, H., Naito, H., Takakura, N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115, 3166-3174 (2010).
25. Sawane, M. et al. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 62, 1970-1980 (2013).
26. Kalin, R. E. et al. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev. Biol. 305, 599-614 (2007).
27. Zeng, X. X., Wilm, T. P., Sepich, D. S., Solnica-Krezel, L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev. Cell 12, 391-402 (2007).
28. Cox, C. M., D'Agostino, S. L., Miller, M. K., Heimark, R. L., Krieg, P. A. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev. Biol. 296, 177-189 (2006).
29. Zeng, H., Vaka, V. R., He, X., Booz, G. W., Chen, J. X. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J. Cell Mol. Med. 19, 1847-1856 (2015).
30. Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839-851 (2009).
31. Duan, L. J., Zhang-Benoit, Y., Fong, G. H. Endothelium-intrinsic requirement for Hif-2alpha during vascular development. Circulation 111, 2227-2232 (2005).
32. Le, B. A. et al. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 26, 7480-7489 (2007).
33. Farquhar, I. et al. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J. Surg. Res. 61, 190-196 (1996).
34. Wafa, K. et al. Desmopressin improves intestinal functional capillary density and decreases leukocyte activation in experimental endotoxemia. Microvasc. Res. (2013).
35. Gaengel, K., Genove, G., Armulik, A., Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 630-638 (2009).
36. Armulik, A., Abramsson, A., Betsholtz, C. Endothelial/pericyte interactions. Circ. Res. 97, 512-523 (2005).
37. Nishioku, T. et al. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol. Neurobiol. 29, 309-316 (2009).
38. Chintalgattu, V. et al. Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci. Transl. Med. 5, 187-69 (2013).
39. Szczepaniak, W. S. et al. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl. Res. 152, 213-224 (2008).
40. Peng, X. et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit Care Med. 169, 1245-1251 (2004).
41. Brueckmann, M. et al. Prognostic value of platelet-derived growth factor in patients with severe sepsis. Growth Factors 25, 15-24 (2007).
42. Takeda, K., Cowan, A., Fong, G. H. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116, 774-781 (2007).
43. Chen, J. X., Stinnett, A. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 57, 3335-3343 (2008).
44. Gu, X., Liu, X. Y., Fagan, A., Gonzalez-Toledo, M. E., Zhao, L. R. Ultrastructural changes in cerebral capillary pericytes in aged Notch3 mutant transgenic mice. Ultrastruct. Pathol. 36, 48-55 (2012).
45. Wang, Y., Pan, L., Moens, C. B., Appel, B. Notch3 establishes brain vascular integrity by regulating pericyte number. Development 141, 307-317 (2014).
46. Boulos, N. et al. Notch3 is essential for regulation of the renal vascular tone. Hypertension 57, 1176-1182 (2011).
47. Zeng, H., Chen, J. X. Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice. PLoS. One. 9, e115974 (2014).
48. Chen, S. C., Tsai, M. H., Wang, H. J., Yu, H. S., Chang, L. W. Vascular permeability alterations induced by arsenic. Hum. Exp. Toxicol. 23, 1-7 (2004).